Clarus Group’s Aspen Aerogels ASPN Stock Holding History

Clarus Group’s Portfolio ASPN Stock Details ASPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-10,504	Closed	-$35.9K	–	128
2026 Q1	$35.9K	Buy	+10,504	New	+$35.4K	0.01%	112

Other funds holding ASPN

KIM LLC Wichita, Kansas $1B AUM 29.68% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

OCMI

Oaktop Capital Management II Chatham, New Jersey $2.35B AUM 214.39% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

NIM

Needham Investment Management New York $3.33B AUM 163.16% 1-Year Est. Return

GKFF

George Kaiser Family Foundation Tulsa, Oklahoma $1.04B AUM 36.93% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Clarus Group's ASPN Position: Q2 2026 in Review

Clarus Group sold out of Aspen Aerogels (ASPN) in Q2 2026, closing a stake of 10,504 shares — an estimated $35.9K sold.

Clarus Group first reported a position in ASPN in Q1 2026 and held it in 1 quarter. The position peaked at $35.9K in Q1 2026. 179 funds tracked by Wall St. Rank hold ASPN as of Q2 2026.

Clarus Group reported no remaining Aspen Aerogels position as of Q2 2026 after selling out during the quarter.
Clarus Group sold 10,504 Aspen Aerogels shares in Q2 2026, an estimated $35.9K.
Clarus Group first reported a position in Aspen Aerogels in Q1 2026 and held it in 1 quarter.
Clarus Group's Aspen Aerogels position peaked at $35.9K in Q1 2026.
179 funds tracked by Wall St. Rank held Aspen Aerogels as of Q2 2026.

Based on Clarus Group's 13F filing for Q2 2026, filed 24 Jul 2026.